Over-expression of lysine-specific demethylase 1 predicts tumor progression and poor prognosis in human esophageal cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 12, 2014, Pages 8929-8934

  Chen, Lujun ^a   Xu, Yun ^a   Xu, Bin ^a   Deng, Haifeng ^a   Zheng, Xiao ^a   Wu, Changping ^a   Jiang, Jingting ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Esophageal cancer; Immunohistochemistry; LSD1; Prognosis

Indexed keywords

HISTONE DEMETHYLASE; KDM1A PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; BIOSYNTHESIS; DISEASE COURSE; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; UPREGULATION;

ADULT; AGED; BIOMARKERS, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HISTONE DEMETHYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; UP-REGULATION;

EID: 84921504444     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Chen L, Luo G, Tan Y, Wei J, Wu C, Zheng L, Zhang X and Xu N. Immunolocalisation of tissue factor in esophageal cancer is correlated with intratumoral angiogenesis and prognosis of the patient. Acta Histochem 2010; 112: 233-239.
3. Chen L, Di D, Luo G, Zheng L, Tan Y, Zhang X and Xu N. Immunochemical staining of MT2-MMP correlates positively to angiogenesis of human esophageal cancer. Anticancer Res 2010; 30: 4363-4368.
4. Chen L, Sun J, Wu H, Zhou S, Tan Y, Tan M, Shan B, Lu B and Zhang X. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother 2011; 60: 1047-1055.
5. Stoner GD and Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737-1746.
6. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H and Goldberg M. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-4337.
7. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA and Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941-953.
8. Chen Y, Yang Y, Wang F, Wan K, Yamane K, Zhang Y and Lei M. Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc Natl Acad Sci U S A 2006; 103: 13956-13961.
9. Amente S, Lania L and Majello B. The histone LSD1 demethylase in stemness and cancer transcription programs. Biochim Biophys Acta 2013; 1829: 981-986.
10. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schule R and Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006; 66: 11341-11347.
11. Zhao ZK, Yu HF, Wang DR, Dong P, Chen L, Wu WG, Ding WJ and Liu YB. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients. World J Gastroenterol 2012; 18: 6651-6656.
12. Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi Z, Jing W and Liang Z. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer. Dig Dis Sci 2013; 58: 1581-1589.
13. Greene FL, Page DL and Fleming ID, et al. AJCC cancer staging manual. 6th edition. New York: Springer-Verlag; 2002.
14. Chen L, Zhou Q, Xu B, Liu J, Shi L, Zhu D, Wu C and Jiang J. MT2-MMP expression associates with tumor progression and angiogenesis in human lung cancer. Int J Clin Exp Pathol 2014; 7: 3469-3477.
15. Zhu X, Zhang J, Zhuang P, Zhu H, Zhang W, Xiong Y, Wu W, Wang L, Tang Z and Sun H. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008; 26: 2707-2716.
16. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH and Pages F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964.
17. Lund AH and van Lohuizen M. Epigenetics and cancer. Genes Dev 2004; 18: 2315-2335.
18. Klose RJ and Zhang Y. Regulation of histone methylation by demethylimination and demethylation. Nat Rev Mol Cell Biol 2007; 8: 307-318.
19. Derr RS, van Hoesel AQ, Benard A, Goossens-Beumer IJ, Sajet A, Dekker-Ensink NG, de Kruijf EM, Bastiaannet E, Smit VT, van de Velde CJ and Kuppen PJ. High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients. BMC Cancer 2014; 14: 604.
20. Hayami S, Kelly JD, Cho HS, Yoshimatsu M, Unoki M, Tsunoda T, Field HI, Neal DE, Yamaue H, Ponder BA, Nakamura Y and Hamamoto R. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 2011; 128: 574-586.
21. Yu Y, Wang B, Zhang K, Lei Z, Guo Y, Xiao H, Wang J, Fan L, Lan C, Wei Y, Ma Q, Lin L, Mao C, Yang X, Chen X, Li Y, Bai Y and Chen D. High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2013; 437: 192-198.
22. Yuan C, Li Z, Qi B, Zhang W, Cheng J and Wang Y. High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer. J Oral Pathol Med 2014; Jul 18. doi: 10.1111/jop.12220. [Epub ahead of print]. PMID: 25040359.
23. Lin Y, Dong C and Zhou BP. Epigenetic regulation of EMT: the Snail story. Curr Pharm Des 2014; 20: 1698-1705.
24. Lin T, Ponn A, Hu X, Law BK and Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010; 29: 4896-4904.